Source: Proteomics. Unidade: FM
Subjects: ESCLEROSE MÚLTIPLA, DOENÇAS NEURODEGENERATIVAS, CÉREBRO (FISIOPATOLOGIA), DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHROTTER, Andreas et al. New milestones in the development of characterization tools for neurodegenerative diseases in proteomics. Proteomics, v. 15, p. 627-629, 2015Tradução . . Disponível em: https://doi.org/10.1002/pmic.201570035. Acesso em: 01 jun. 2024.APA
Schrotter, A., El Magraoui, F., Marcus, K., Park, Y. M., Meyer, H. E., & Grinberg, L. T. (2015). New milestones in the development of characterization tools for neurodegenerative diseases in proteomics. Proteomics, 15, 627-629. doi:10.1002/pmic.201570035NLM
Schrotter A, El Magraoui F, Marcus K, Park YM, Meyer HE, Grinberg LT. New milestones in the development of characterization tools for neurodegenerative diseases in proteomics [Internet]. Proteomics. 2015 ; 15 627-629.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/pmic.201570035Vancouver
Schrotter A, El Magraoui F, Marcus K, Park YM, Meyer HE, Grinberg LT. New milestones in the development of characterization tools for neurodegenerative diseases in proteomics [Internet]. Proteomics. 2015 ; 15 627-629.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/pmic.201570035